These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24209905)
1. Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line. Gu H; Zhan X; Zhang G; Yan L; Cho WC; Li M; Liu T; Chen Z BMC Cancer; 2013 Nov; 13():536. PubMed ID: 24209905 [TBL] [Abstract][Full Text] [Related]
2. RKIP and 14-3-3ε exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently. Yan L; Gu H; Li J; Xu M; Liu T; Shen Y; Chen B; Zhang G Dig Dis Sci; 2013 Feb; 58(2):389-96. PubMed ID: 22899242 [TBL] [Abstract][Full Text] [Related]
3. RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN. Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B Tumour Biol; 2014 Dec; 35(12):11949-58. PubMed ID: 25172097 [TBL] [Abstract][Full Text] [Related]
4. RKIP expression associated with gastric cancer cell invasion and metastasis. Jia B; Liu H; Kong Q; Li B Tumour Biol; 2012 Aug; 33(4):919-25. PubMed ID: 22246605 [TBL] [Abstract][Full Text] [Related]
5. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway. Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433 [TBL] [Abstract][Full Text] [Related]
6. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. Zhang XM; Zhou C; Gu H; Yan L; Zhang GY Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233 [TBL] [Abstract][Full Text] [Related]
7. Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro. Lei X; Chang L; Ye W; Jiang C; Zhang Z Int J Clin Exp Pathol; 2015; 8(11):14214-20. PubMed ID: 26823735 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma]. Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553 [TBL] [Abstract][Full Text] [Related]
9. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance. Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514 [TBL] [Abstract][Full Text] [Related]
10. The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro. Hao C; Wei S; Tong Z; Li S; Shi Y; Wang X; Zhu ZH Tumour Biol; 2012 Aug; 33(4):1159-67. PubMed ID: 22373584 [TBL] [Abstract][Full Text] [Related]
11. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression. Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415 [TBL] [Abstract][Full Text] [Related]
13. Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer. Nisimova L; Wen S; Cross-Knorr S; Rogers AB; Moss SF; Chatterjee D Crit Rev Oncog; 2014; 19(6):469-81. PubMed ID: 25597356 [TBL] [Abstract][Full Text] [Related]
14. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Lee HC; Tian B; Sedivy JM; Wands JR; Kim M Gastroenterology; 2006 Oct; 131(4):1208-17. PubMed ID: 17030190 [TBL] [Abstract][Full Text] [Related]
15. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Yeung KC; Rose DW; Dhillon AS; Yaros D; Gustafsson M; Chatterjee D; McFerran B; Wyche J; Kolch W; Sedivy JM Mol Cell Biol; 2001 Nov; 21(21):7207-17. PubMed ID: 11585904 [TBL] [Abstract][Full Text] [Related]
16. Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2. Deiss K; Kisker C; Lohse MJ; Lorenz K J Biol Chem; 2012 Jul; 287(28):23407-17. PubMed ID: 22610096 [TBL] [Abstract][Full Text] [Related]
17. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study. Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299 [TBL] [Abstract][Full Text] [Related]
18. RKIP inhibits the malignant phenotypes of gastric cancer cells. Zhang XM; Gu H; Yan L; Zhang GY Neoplasma; 2013; 60(2):196-202. PubMed ID: 23259789 [TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Kim SO; Kim MR Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610 [TBL] [Abstract][Full Text] [Related]
20. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]